{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:34:48Z","timestamp":1758476088830},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ischemic cerebrovascular disease (ICVD) is a major cause of mortality and disability worldwide and is often caused by atherosclerosis. As a systemic disease, atherosclerosis usually affects multiple vascular beds, mainly including cerebral, coronary, and peripheral arteries. Therefore, ICVD is easily complicated by lower-extremity peripheral arterial disease (PAD). ICVD patients\u00a0with PAD\u00a0have more serious symptoms and a worse prognosis, however, neurologists might neglect the evaluation and management of the coexistent PAD, and there is still a lack of consensuses about the diagnosis and treatment for such patients. By summarizing relevant research progresses, this review showed that duplex ultrasound had more advantages in the early screening and evaluation of PAD in ICVD patients among multiple methods to diagnose PAD. Furthermore, the current evidence seems to support that single-drug antiplatelet can be used as the basic treatment, and new antithrombotic strategies, such as ticagrelor only or aspirin combined with low-dose rivaroxaban are expected to further reduce the incidence of stroke for ICVD patients with PAD. More effective treatments would be explored by large-scale trials to guide the clinical management to prevent secondary stroke for such patients.<\/jats:p>","DOI":"10.1186\/s40001-023-01050-5","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T09:04:10Z","timestamp":1677143050000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Early identification and treatment for peripheral arterial disease in patients with ischemic cerebrovascular disease"],"prefix":"10.1186","volume":"28","author":[{"given":"Lu-guang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"issue":"8","key":"1050_CR1","doi-asserted-by":"publisher","first-page":"8963","DOI":"10.21037\/apm-21-1759","volume":"10","author":"J Zhou","year":"2021","unstructured":"Zhou J, Shan Y, Hu P. A systematic review and meta-analysis on transcranial Doppler in diagnosing ischemic cerebrovascular disease. Ann Pall Med. 2021;10(8):8963\u201371.","journal-title":"Ann Pall Med"},{"issue":"2","key":"1050_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1055\/s-0038-1649503","volume":"38","author":"M Katan","year":"2018","unstructured":"Katan M, Luft A. Global burden of stroke. Semin Neurol. 2018;38(2):208\u201311.","journal-title":"Semin Neurol"},{"issue":"2","key":"1050_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1001\/jamaneurol.2017.3960","volume":"75","author":"T Hoshino","year":"2018","unstructured":"Hoshino T, Sissani L, Labreuche J, Ducrocq G, Lavall\u00e9e PC, Meseguer E, et al. Prevalence of systemic atherosclerosis burdens and overlapping stroke etiologies and their associations with long-term vascular prognosis in stroke with intracranial atherosclerotic disease. JAMA Neurol. 2018;75(2):203\u201311.","journal-title":"JAMA Neurol"},{"issue":"5","key":"1050_CR4","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.01.029","volume":"25","author":"H Naito","year":"2016","unstructured":"Naito H, Naka H, Kobayashi M, Kanaya Y, Naito K, Kurashige T, et al. Prevalences of peripheral arterial disease diagnosed by computed tomography angiography in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2016;25(5):1128\u201334.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"10","key":"1050_CR5","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.amjmed.2019.04.043","volume":"132","author":"U Campia","year":"2019","unstructured":"Campia U, Gerhard-Herman M, Piazza G, Goldhaber SZ. Peripheral artery disease: past, present, and future. Am J Med. 2019;132(10):1133\u201341.","journal-title":"Am J Med"},{"issue":"3","key":"1050_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrcardio.2016.179","volume":"14","author":"FG Fowkes","year":"2017","unstructured":"Fowkes FG, Aboyans V, Fowkes FJ, McDermott MM, Sampson UK, Criqui MH. Peripheral artery disease: epidemiology and global perspectives. Nat Rev Cardiol. 2017;14(3):156\u201370.","journal-title":"Nat Rev Cardiol"},{"issue":"19","key":"1050_CR7","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1093\/eurheartj\/ehp355","volume":"30","author":"MJ Alberts","year":"2009","unstructured":"Alberts MJ, Bhatt DL, Mas JL, Ohman EM, Hirsch AT, R\u00f6ther J, et al. Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. Eur Heart J. 2009;30(19):2318\u201326.","journal-title":"Eur Heart J"},{"issue":"1","key":"1050_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12883-019-1485-1","volume":"19","author":"Z Pan","year":"2019","unstructured":"Pan Z, Wang R, Li L, Zhang H. Correlation between significant asymptomatic carotid artery stenosis and severity of peripheral arterial occlusive disease in the lower limb: a retrospective study on 200 patients. BMC Neurol. 2019;19(1):259.","journal-title":"BMC Neurol"},{"issue":"11","key":"1050_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104370","volume":"28","author":"YY Shin","year":"2019","unstructured":"Shin YY, Ha SH, Woo HG, Heo SH, Chang DI, Kim BJ. Subclinical peripheral arterial disease in patients with acute ischemic stroke: a study with ultrasonography. J Stroke Cerebrovasc Dis. 2019;28(11): 104370.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"1050_CR10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.atherosclerosis.2015.06.029","volume":"241","author":"L Razzouk","year":"2015","unstructured":"Razzouk L, Rockman CB, Patel MR, Guo Y, Adelman MA, Riles TS, et al. Co-existence of vascular disease in different arterial beds: peripheral artery disease and carotid artery stenosis\u2013data from life line screening(\u00ae). Atherosclerosis. 2015;241(2):687\u201391.","journal-title":"Atherosclerosis"},{"issue":"1","key":"1050_CR11","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.09.010601","volume":"9","author":"P Song","year":"2019","unstructured":"Song P, Rudan D, Wang M, Chang X, Rudan I. National and subnational estimation of the prevalence of peripheral artery disease (PAD) in China: a systematic review and meta-analysis. J Glob Health. 2019;9(1): 010601.","journal-title":"J Glob Health"},{"issue":"7","key":"1050_CR12","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1080\/00325481.2020.1788319","volume":"132","author":"K Zhang","year":"2020","unstructured":"Zhang K, Lin Q, Zhang T, Guo D, Cao L. Contemporary Prevalence and risk factors of carotid artery stenosis in asymptomatic low-income Chinese individuals: a population-based study. Postgrad Med. 2020;132(7):650\u20136.","journal-title":"Postgrad Med"},{"issue":"6","key":"1050_CR13","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1177\/2047487312452968","volume":"21","author":"LH Eraso","year":"2014","unstructured":"Eraso LH, Fukaya E, Mohler ER 3rd, Xie D, Sha D, Berger JS. Peripheral arterial disease, prevalence and cumulative risk factor profile analysis. Eur J Prev Cardiol. 2014;21(6):704\u201311.","journal-title":"Eur J Prev Cardiol"},{"issue":"8","key":"1050_CR14","first-page":"1138","volume":"67","author":"AS Rahman","year":"2017","unstructured":"Rahman AS, Akhtar SW, Jamal Q, Sultana N, Siddiqui MA, Hassan Z. Ischaemic stroke and peripheral artery disease. J Pak Med Assoc. 2017;67(8):1138\u201344.","journal-title":"J Pak Med Assoc"},{"issue":"6","key":"1050_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014163","volume":"98","author":"HJ Jung","year":"2019","unstructured":"Jung HJ, Lee SS, Kim HY, Park BS, Kim DI, Nam KJ, et al. Association between carotid artery stenosis and peripheral artery disease: evaluation by screening carotid ultrasonography (cross-sectional study). Medicine (Baltimore). 2019;98(6): e14163.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"1050_CR16","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.01.049","volume":"25","author":"N Barreto-Neto","year":"2016","unstructured":"Barreto-Neto N, Barros AD, Jesus PA, Reis CC, Jesus ML, Ferreira IL, et al. Low ankle-brachial index is a simple physical exam sign predicting intracranial atherosclerotic stenosis in ischemic stroke patients. J Stroke Cerebrovasc Dis. 2016;25(6):1417\u201320.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"11","key":"1050_CR17","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S1474-4422(13)70195-9","volume":"12","author":"CA Holmstedt","year":"2013","unstructured":"Holmstedt CA, Turan TN, Chimowitz MI. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2013;12(11):1106\u201314.","journal-title":"Lancet Neurol"},{"issue":"2","key":"1050_CR18","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1161\/STROKEAHA.115.011321","volume":"47","author":"JB Hong","year":"2016","unstructured":"Hong JB, Leonards CO, Endres M, Siegerink B, Liman TG. Ankle-brachial index and recurrent stroke risk: meta-analysis. Stroke. 2016;47(2):317\u201322.","journal-title":"Stroke"},{"issue":"22","key":"1050_CR19","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1016\/j.jacc.2018.09.041","volume":"72","author":"AP Kithcart","year":"2018","unstructured":"Kithcart AP, Beckman JA. ACC\/AHA versus ESC guidelines for diagnosis and management of peripheral artery disease: JACC guideline comparison. J Am Coll Cardiol. 2018;72(22):2789\u2013801.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1050_CR20","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1161\/STROKEAHA.118.023534","volume":"50","author":"BJ Kolls","year":"2019","unstructured":"Kolls BJ, Sapp S, Rockhold FW, Jordan JD, Dombrowski KE, Fowkes FGR, et al. Stroke in patients with peripheral artery disease. Stroke. 2019;50(6):1356\u201363.","journal-title":"Stroke"},{"issue":"9","key":"1050_CR21","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","volume":"116","author":"MH Criqui","year":"2015","unstructured":"Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116(9):1509\u201326.","journal-title":"Circ Res"},{"issue":"12","key":"1050_CR22","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1161\/CIRCRESAHA.121.318535","volume":"128","author":"AW Aday","year":"2021","unstructured":"Aday AW, Matsushita K. Epidemiology of peripheral artery disease and polyvascular disease. Circ Res. 2021;128(12):1818\u201332.","journal-title":"Circ Res"},{"issue":"2","key":"1050_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1024\/0301-1526\/a000897","volume":"50","author":"AG Kieback","year":"2021","unstructured":"Kieback AG, G\u00e4hwiler R, Thalhammer C. PAD screening: why? whom? when? how?\u2014a systematic review. Vasa. 2021;50(2):85\u201391.","journal-title":"Vasa"},{"issue":"9","key":"1050_CR24","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"V Aboyans","year":"2018","unstructured":"Aboyans V, Ricco JB, Bartelink MEL, Bj\u00f6rck M, Brodmann M, Cohnert T, et al. 2017 esc guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the european society for vascular surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries endorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763\u2013816.","journal-title":"Eur Heart J"},{"issue":"3","key":"1050_CR25","first-page":"np43","volume":"22","author":"MD Gerhard-Herman","year":"2017","unstructured":"Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary. Vasc Med (London, England). 2017;22(3):np43.","journal-title":"Vasc Med (London, England)."},{"issue":"7","key":"1050_CR26","doi-asserted-by":"publisher","first-page":"678","DOI":"10.4065\/mcp.2010.0133","volume":"85","author":"JW Olin","year":"2010","unstructured":"Olin JW, Sealove BA. Peripheral artery disease: current insight into the disease and its diagnosis and management. Mayo Clin Proc. 2010;85(7):678\u201392.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"1050_CR27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ejvs.2005.01.015","volume":"29","author":"MF Caruana","year":"2005","unstructured":"Caruana MF, Bradbury AW, Adam DJ. The validity, reliability, reproducibility and extended utility of ankle to brachial pressure index in current vascular surgical practice. Eur J Vasc Endovasc Surg. 2005;29(5):443\u201351.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"9","key":"1050_CR28","first-page":"Cd010680","volume":"9","author":"F Crawford","year":"2016","unstructured":"Crawford F, Welch K, Andras A, Chappell FM. Ankle brachial index for the diagnosis of lower limb peripheral arterial disease. Cochrane Database Syst Rev. 2016;9(9):Cd010680.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1050_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13047-020-00389-w","volume":"13","author":"SL Casey","year":"2020","unstructured":"Casey SL, Lanting SM, Chuter VH. The ankle brachial index in people with and without diabetes: intra-tester reliability. J Foot Ankle Res. 2020;13(1):21.","journal-title":"J Foot Ankle Res"},{"issue":"1","key":"1050_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12938-018-0494-4","volume":"17","author":"E Shabani Varaki","year":"2018","unstructured":"Shabani Varaki E, Gargiulo GD, Penkala S, Breen PP. Peripheral vascular disease assessment in the lower limb: a review of current and emerging non-invasive diagnostic methods. Biomed Eng Online. 2018;17(1):61.","journal-title":"Biomed Eng Online"},{"issue":"4","key":"1050_CR31","doi-asserted-by":"publisher","first-page":"306","DOI":"10.23736\/S0392-9590.21.04524-7","volume":"40","author":"O Martinelli","year":"2021","unstructured":"Martinelli O, Alunno A, Jabbour J, Cuozzo S, Gattuso R. Duplex ultrasound as a reliable alternative to CT angiography for treatment planning of peripheral artery disease. Int Angiol. 2021;40(4):306\u201314.","journal-title":"Int Angiol"},{"issue":"3","key":"1050_CR32","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jvs.2019.05.050","volume":"71","author":"AF AbuRahma","year":"2020","unstructured":"AbuRahma AF, Adams E, AbuRahma J, Mata LA, Dean LS, Caron C, et al. Critical analysis and limitations of resting ankle-brachial index in the diagnosis of symptomatic peripheral arterial disease patients and the role of diabetes mellitus and chronic kidney disease. J Vasc Surg. 2020;71(3):937\u201345.","journal-title":"J Vasc Surg"},{"issue":"1","key":"1050_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12872-020-01821-6","volume":"21","author":"E Ugwu","year":"2021","unstructured":"Ugwu E, Anyanwu A, Olamoyegun M. Ankle brachial index as a surrogate to vascular imaging in evaluation of peripheral artery disease in patients with type 2 diabetes. BMC Cardiovasc Disord. 2021;21(1):10.","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"1050_CR34","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1253\/circj.72.605","volume":"72","author":"X Guo","year":"2008","unstructured":"Guo X, Li J, Pang W, Zhao M, Luo Y, Sun Y, et al. Sensitivity and specificity of ankle-brachial index for detecting angiographic stenosis of peripheral arteries. Circ J. 2008;72(4):605\u201310.","journal-title":"Circ J"},{"key":"1050_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2021.09.012","volume":"335","author":"P Poredo\u0161","year":"2021","unstructured":"Poredo\u0161 P, Cevc M, Blinc A. Characteristics of atherosclerosis in femoropopliteal artery and its clinical relevance. Atherosclerosis. 2021;335:31\u201340.","journal-title":"Atherosclerosis"},{"issue":"4","key":"1050_CR36","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ejvs.2010.06.002","volume":"40","author":"JP Eiberg","year":"2010","unstructured":"Eiberg JP, Gr\u00f8nvall Rasmussen JB, Hansen MA, Schroeder TV. Duplex ultrasound scanning of peripheral arterial disease of the lower limb. Eur J Vasc Endovasc Surg. 2010;40(4):507\u201312.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"1050_CR37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.avsg.2020.10.027","volume":"73","author":"E Garc\u00eda-Rivera","year":"2021","unstructured":"Garc\u00eda-Rivera E, Cenizo-Revuelta N, Ib\u00e1\u00f1ez-Mara\u00f1a MA, Fidalgo-Domingos L, Est\u00e9vez-Fern\u00e1ndez I, Flota-Ruiz C, et al. Doppler ultrasound as a unique diagnosis test in peripheral arterial disease. Ann Vasc Surg. 2021;73:205\u201310.","journal-title":"Ann Vasc Surg"},{"issue":"4","key":"1050_CR38","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jvs.2007.11.023","volume":"47","author":"DP Flanigan","year":"2008","unstructured":"Flanigan DP, Ballard JL, Robinson D, Galliano M, Blecker G, Harward TR. Duplex ultrasound of the superficial femoral artery is a better screening tool than ankle-brachial index to identify at risk patients with lower extremity atherosclerosis. J Vasc Surg. 2008;47(4):789\u201392 (discussion 92\u20133).","journal-title":"J Vasc Surg"},{"issue":"1","key":"1050_CR39","first-page":"1","volume":"10","author":"Chinese Medical Association","year":"2016","unstructured":"Chinese Medical Association. Guidelines for diagnosis and treatment of arteriosclerosis obliterans of lower limbs. Chin Arch Gen Surg. 2016;10(1):1\u201318 (in Chinese).","journal-title":"Chin Arch Gen Surg"},{"issue":"33","key":"1050_CR40","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J"},{"issue":"7","key":"1050_CR41","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","volume":"52","author":"DO Kleindorfer","year":"2021","unstructured":"Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the american heart association\/american stroke association. Stroke. 2021;52(7):e364\u2013467.","journal-title":"Stroke"},{"issue":"2","key":"1050_CR42","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1161\/HYPERTENSIONAHA.115.06722","volume":"67","author":"WC Cushman","year":"2016","unstructured":"Cushman WC, Whelton PK, Fine LJ, Wright JT Jr, Reboussin DM, Johnson KC, et al. SPRINT trial results: latest news in hypertension management. Hypertension. 2016;67(2):263\u20135.","journal-title":"Hypertension"},{"issue":"1","key":"1050_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11906-020-01120-7","volume":"23","author":"D G\u0105secki","year":"2020","unstructured":"G\u0105secki D, Kwarciany M, Kowalczyk K, Narkiewicz K, Karaszewski B. Blood pressure management in acute ischemic stroke. Curr Hypertens Rep. 2020;23(1):3.","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"1050_CR44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1024\/0301-1526\/a000689","volume":"47","author":"K Gebauer","year":"2018","unstructured":"Gebauer K, Reinecke H. PCSK9 inhibition for LDL lowering and beyond\u2014implications for patients with peripheral artery disease. Vasa. 2018;47(3):165\u201376.","journal-title":"Vasa"},{"issue":"3","key":"1050_CR45","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jacc.2018.04.054","volume":"72","author":"RS Rosenson","year":"2018","unstructured":"Rosenson RS, Hegele RA, Fazio S, Cannon CP. The evolving future of PCSK9 inhibitors. J Am Coll Cardiol. 2018;72(3):314\u201329.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1050_CR46","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","volume":"137","author":"MP Bonaca","year":"2018","unstructured":"Bonaca MP, Nault P, Giugliano RP, Keech AC, Pineda AL, Kanevsky E, et al. Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk). Circulation. 2018;137(4):338\u201350.","journal-title":"Circulation"},{"issue":"5","key":"1050_CR47","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017948","volume":"10","author":"M Alkhalil","year":"2021","unstructured":"Alkhalil M, Kuzemczak M, Whitehead N, Kavvouras C, D\u017eav\u00edk V. Meta-analysis of intensive lipid-lowering therapy in patients with polyvascular disease. J Am Heart Assoc. 2021;10(5): e017948.","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"1050_CR48","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1161\/CIRCRESAHA.121.318258","volume":"128","author":"MP Bonaca","year":"2021","unstructured":"Bonaca MP, Hamburg NM, Creager MA. Contemporary medical management of peripheral artery disease. Circ Res. 2021;128(12):1868\u201384.","journal-title":"Circ Res"},{"issue":"2","key":"1050_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1024\/0301-1526\/a000676","volume":"47","author":"DM Olinic","year":"2018","unstructured":"Olinic DM, Tataru DA, Homorodean C, Spinu M, Olinic M. Antithrombotic treatment in peripheral artery disease. Vasa. 2018;47(2):99\u2013108.","journal-title":"Vasa"},{"issue":"9","key":"1050_CR50","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1001\/jama.2010.221","volume":"303","author":"FG Fowkes","year":"2010","unstructured":"Fowkes FG, Price JF, Stewart MC, Butcher I, Leng GC, Pell AC, et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA. 2010;303(9):841\u20138.","journal-title":"JAMA"},{"key":"1050_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1840","volume":"337","author":"J Belch","year":"2008","unstructured":"Belch J, MacCuish A, Campbell I, Cobbe S, Taylor R, Prescott R, et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ. 2008;337: a1840.","journal-title":"BMJ"},{"key":"1050_CR52","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.pcad.2021.02.009","volume":"65","author":"AA Behroozian","year":"2021","unstructured":"Behroozian AA, Beckman JA. Asymptomatic peripheral artery disease: silent but deadly. Prog Cardiovasc Dis. 2021;65:2\u20138.","journal-title":"Prog Cardiovasc Dis"},{"issue":"31\u201332","key":"1050_CR53","first-page":"528","volume":"118","author":"D Hardung","year":"2021","unstructured":"Hardung D, Behne A, Boral M, Giesche C, Langhoff R. Antithrombotic treatment for peripheral arterial occlusive disease. Dtsch Arztebl Int. 2021;118(31\u201332):528\u201335.","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"1050_CR54","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1161\/ATVBAHA.119.312142","volume":"40","author":"GH Bevan","year":"2020","unstructured":"Bevan GH, White Solaru KT. Evidence-based medical management of peripheral artery disease. Arterioscler Thromb Vasc Biol. 2020;40(3):541\u201353.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7329","key":"1050_CR55","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists' Collaboration","year":"2002","unstructured":"AT Collaborative. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71\u201386.","journal-title":"BMJ"},{"issue":"9038","key":"1050_CR56","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"M Gent","year":"1996","unstructured":"Dennis M, CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348(9038):1329\u201339.","journal-title":"Lancet"},{"issue":"1","key":"1050_CR57","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa1611688","volume":"376","author":"WR Hiatt","year":"2017","unstructured":"Hiatt WR, Fowkes FG, Heizer G, Berger JS, Baumgartner I, Held P, et al. Ticagrelor versus clopidogrel in symptomatic peripheral artery disease. N Engl J Med. 2017;376(1):32\u201340.","journal-title":"N Engl J Med"},{"issue":"7","key":"1050_CR58","doi-asserted-by":"publisher","first-page":"e468","DOI":"10.1161\/STR.0000000000000377","volume":"52","author":"DL Brown","year":"2021","unstructured":"Brown DL, Levine DA, Albright K, Kapral MK, Leung LY, Reeves MJ, et al. Benefits and risks of dual versus single antiplatelet therapy for secondary stroke prevention: a systematic review for the 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke. 2021;52(7):e468\u201379.","journal-title":"Stroke"},{"issue":"2","key":"1050_CR59","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/eurheartj\/ehn534","volume":"30","author":"PP Cacoub","year":"2009","unstructured":"Cacoub PP, Bhatt DL, Steg PG, Topol EJ, Creager MA. Patients with peripheral arterial disease in the CHARISMA trial. Eur Heart J. 2009;30(2):192\u2013201.","journal-title":"Eur Heart J"},{"issue":"4","key":"1050_CR60","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jvs.2010.04.027","volume":"52","author":"JJ Belch","year":"2010","unstructured":"Belch JJ, Dormandy J, Biasi GM, Cairols M, Diehm C, Eikelboom B, et al. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg. 2010;52(4):825\u201333.","journal-title":"J Vasc Surg"},{"issue":"23","key":"1050_CR61","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1016\/j.jacc.2016.03.524","volume":"67","author":"MP Bonaca","year":"2016","unstructured":"Bonaca MP, Bhatt DL, Storey RF, Steg PG, Cohen M, Kuder J, et al. Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease. J Am Coll Cardiol. 2016;67(23):2719\u201328.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1050_CR62","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1136\/svn-2020-000737","volume":"6","author":"CH Tan","year":"2021","unstructured":"Tan CH, Wu AG, Sia CH, Leow AS, Chan BP, Sharma VK, et al. Cilostazol for secondary stroke prevention: systematic review and meta-analysis. Stroke Vasc Neurol. 2021;6(3):410\u201323.","journal-title":"Stroke Vasc Neurol"},{"issue":"6","key":"1050_CR63","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1474-4422(19)30148-6","volume":"18","author":"K Toyoda","year":"2019","unstructured":"Toyoda K, Uchiyama S, Yamaguchi T, Easton JD, Kimura K, Hoshino H, et al. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial. Lancet Neurol. 2019;18(6):539\u201348.","journal-title":"Lancet Neurol"},{"issue":"13","key":"1050_CR64","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1080\/14656566.2020.1774556","volume":"21","author":"H Essa","year":"2020","unstructured":"Essa H, Torella F, Lip GYH. Current and emerging drug treatment strategies for peripheral arterial disease. Expert Opin Pharmacother. 2020;21(13):1603\u201316.","journal-title":"Expert Opin Pharmacother"},{"issue":"14","key":"1050_CR65","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s40265-020-01397-7","volume":"80","author":"LJ Scott","year":"2020","unstructured":"Scott LJ. Rivaroxaban: a review for secondary CV prevention in CAD and PAD. Drugs. 2020;80(14):1465\u201375.","journal-title":"Drugs"},{"issue":"3","key":"1050_CR66","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1161\/ATVBAHA.110.202978","volume":"30","author":"E Perzborn","year":"2010","unstructured":"Perzborn E, Roehrig S, Straub A, Kubitza D, Mueck W, Laux V. Rivaroxaban: a new oral factor Xa inhibitor. Arterioscler Thromb Vasc Biol. 2010;30(3):376\u201381.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"1050_CR67","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1161\/CIRCULATIONAHA.118.035864","volume":"139","author":"M Sharma","year":"2019","unstructured":"Sharma M, Hart RG, Connolly SJ, Bosch J, Shestakovska O, Ng KKH, et al. Stroke outcomes in the COMPASS trial. Circulation. 2019;139(9):1134\u201345.","journal-title":"Circulation"},{"issue":"10117","key":"1050_CR68","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","volume":"391","author":"SS Anand","year":"2018","unstructured":"Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, et al. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet. 2018;391(10117):219\u201329.","journal-title":"Lancet"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01050-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01050-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01050-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T09:06:51Z","timestamp":1677143211000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01050-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1050"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01050-5","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"assertion":[{"value":"14 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}